1. Home
  2. ARVN vs WDH Comparison

ARVN vs WDH Comparison

Compare ARVN & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • WDH
  • Stock Information
  • Founded
  • ARVN 2015
  • WDH 2016
  • Country
  • ARVN United States
  • WDH China
  • Employees
  • ARVN 430
  • WDH N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • WDH Specialty Insurers
  • Sector
  • ARVN Health Care
  • WDH Finance
  • Exchange
  • ARVN Nasdaq
  • WDH Nasdaq
  • Market Cap
  • ARVN 676.2M
  • WDH 694.4M
  • IPO Year
  • ARVN 2018
  • WDH 2021
  • Fundamental
  • Price
  • ARVN $9.45
  • WDH $1.80
  • Analyst Decision
  • ARVN Buy
  • WDH
  • Analyst Count
  • ARVN 23
  • WDH 0
  • Target Price
  • ARVN $17.61
  • WDH N/A
  • AVG Volume (30 Days)
  • ARVN 2.6M
  • WDH 400.1K
  • Earning Date
  • ARVN 11-04-2025
  • WDH 12-10-2025
  • Dividend Yield
  • ARVN N/A
  • WDH 3.37%
  • EPS Growth
  • ARVN N/A
  • WDH 71.77
  • EPS
  • ARVN N/A
  • WDH 0.17
  • Revenue
  • ARVN $372,800,000.00
  • WDH $416,345,794.00
  • Revenue This Year
  • ARVN $1.01
  • WDH N/A
  • Revenue Next Year
  • ARVN N/A
  • WDH $7.72
  • P/E Ratio
  • ARVN N/A
  • WDH $10.62
  • Revenue Growth
  • ARVN 299.57
  • WDH 9.39
  • 52 Week Low
  • ARVN $5.90
  • WDH $0.97
  • 52 Week High
  • ARVN $29.61
  • WDH $2.18
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 57.54
  • WDH 45.88
  • Support Level
  • ARVN $9.01
  • WDH $1.76
  • Resistance Level
  • ARVN $9.55
  • WDH $1.84
  • Average True Range (ATR)
  • ARVN 0.49
  • WDH 0.05
  • MACD
  • ARVN -0.10
  • WDH -0.01
  • Stochastic Oscillator
  • ARVN 44.37
  • WDH 28.05

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About WDH Waterdrop Inc. (each representing the right to receive 10)

Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.

Share on Social Networks: